|Videos|July 14, 2021

Dr. Casey Seideman on ensuring women are considered for AUA awards

Author(s)Urology Times staff

A study recently published in the Journal of Urology highlighted how women are underrepresented in receiving recognition awards from the American Urological Association (AUA). In this video, Casey Seideman, MD, a researcher on the study, discusses steps that can be taken to ensure women are considered for AUA awards. Seideman is assistant professor of Urology, School of Medicine, Oregon Health & Science University.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Jessica Yih, MD, highlights data on testosterone therapy in women

ByJessica M. Yih, MD

August 11th 2026

Pearls & Perspectives: Wearable Technology and the Future of Sexual Health, With Elliot Justin, MD

ByAmy M. Pearlman, MD,Larry Lipshultz, MD,Elliot Justin, MD, FACEP

August 5th 2026

Pearls & Perspectives: Bridging Gaps in Functional Urology Care, With Diane Newman, DNP, FAAN, BCB-PMD, and Stuart Hart, MD, MBA, MS

ByAmy M. Pearlman, MD,Larry Lipshultz, MD,Diane K. Newman, DNP, FAAN, BCB-PMD,Stuart Hart, MD, MBA, MS

July 7th 2026

Pearls & Perspectives: The Power of Advocacy in Sexual Medicine, With Rachel Rubin, MD

ByAmy M. Pearlman, MD,Larry Lipshultz, MD,Rachel Rubin, MD

June 23rd 2026

Pearls & Perspectives: The Evolving Landscape of Female Pelvic Health, With Annah J. Vollstedt, MD

ByAmy M. Pearlman, MD,Annah J. Vollstedt MD

June 9th 2026

Latest CME

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom

The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD

Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy

FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent

Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery